Development
CME Group Inc.
CME
$285.75
$3.541.25%
NASDAQ
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 7.87% | -2.21% | |||
| Total Other Revenue | 3.53% | 7.59% | |||
| Total Revenue | 7.60% | -1.66% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 7.60% | -1.66% | |||
| SG&A Expenses | 3.80% | -0.59% | |||
| Depreciation & Amortization | -2.27% | -1.12% | |||
| Other Operating Expenses | 57.86% | -1.96% | |||
| Total Operating Expenses | 6.97% | -0.79% | |||
| Operating Income | 8.00% | -2.19% | |||
| Income Before Tax | 3.25% | -4.14% | |||
| Income Tax Expenses | -14.59% | -6.16% | |||
| Earnings from Continuing Operations | 8.58% | -3.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.58% | -3.52% | |||
| EBIT | 8.00% | -2.19% | |||
| EBITDA | 7.00% | -2.09% | |||
| EPS Basic | 8.52% | -3.54% | |||
| Normalized Basic EPS | 3.20% | -4.16% | |||
| EPS Diluted | 8.70% | -3.70% | |||
| Normalized Diluted EPS | 3.23% | -4.19% | |||
| Average Basic Shares Outstanding | 0.05% | 0.02% | |||
| Average Diluted Shares Outstanding | 0.02% | 0.05% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.08% | 0.04% | |||